St. Olav's University Hospital is the hospital in Trondheim, Norway located at Øya. It is part of St. Olavs Hospital Trust that operates all the hospitals in Sør-Trøndelag and thus indirectly state owned.

During the past decade, St Olavs Hospital conducted 214 clinical trials. In the 10-year time frame, 214 clinical trials started and 18 clinical trials were completed, i.e. on average, 8.4% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 10 clinical trials were completed. i.e. 14.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Olavs Hospital" #1 sponsor was "Norwegian University of Science and Technology" with 126 trials, followed by "St. Olavs Hospital" with 57 trials sponsored, "Oslo University Hospital" with 35 trials sponsored, "Haukeland University Hospital" with 16 trials sponsored and "Pfizer" with 16 trials sponsored. Other sponsors include 115 different institutions and companies that sponsored additional 86 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Olavs Hospital" #1 collaborator was "St. Olavs Hospital" with 151 trials as a collaborator, "Norwegian University of Science and Technology" with 50 trials as a collaborator, "University Hospital of North Norway" with 42 trials as a collaborator, "Haukeland University Hospital" with 40 trials as a collaborator and "Alesund Hospital" with 36 trials as a collaborator. Other collaborators include 602 different institutions and companies that were collaborators in the rest 282 trials.

According to Clinical.Site data, the most researched conditions in "St Olavs Hospital" are "Obesity, Morbid" (28 trials), "Multiple Myeloma" (11 trials), "Cancer" (9 trials), "Obesity" (9 trials) and "Pain" (7 trials). Many other conditions were trialed in "St Olavs Hospital" in a lesser frequency.

Most popular intervention types in "St Olavs Hospital" are "Drug" (170 trials), "Other" (57 trials), "Procedure" (51 trials), "Behavioral" (47 trials) and "Device" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Dexamethasone" (8 trials), "placebo" (6 trials), "Cyclophosphamide" (4 trials) and "Irinotecan" (4 trials). Other intervention names were less common.

The vast majority of trials in "St Olavs Hospital" are 320 trials for "All" genders, 31 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are 145 active trials in "St Olavs Hospital". 1 are not yet recruiting, 108 are recruiting, 34 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 176 completed trials in St Olavs Hospital, 1 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in St Olavs Hospital, 12 "Phase 1" clinical trials were conducted, 61 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 117 trials that are defined as “Not Applicable".

St Olavs Hospital has several departments that took part in Clinical trials: "Department of Endocrinology, St. Olavs Hospital" - 23 trials, "Østmarka Psychiatric Department, St. Olavs Hospital" - 4 trials, "St. Olavs University Hospital, Dept of Paediatrics" - 2 trials, "Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim" - 6 trials, "Tiller DPS" - 3 trials, "St. Olavs University Hospital - Department of Physical Medicine and Rehabilitation" - 2 trials, "Hematologisk seksjon, St.Olav Hospital" - 2 trials, "St Olavs Hospital Stroke Unit" - 2 trials